Immediate-effect ibuprofen-containing medicament and its use

US6066332A · kind A · utility

Assignees

• ALFATEC-Pharm GmbH · DE
• Paz Arzneimittelentwicklungsgesellschaft mbH · DE

Inventors

• Jens-Christian Wunderlich · Heidelberg, DE
• Otto Schuster · Bad Soden, DE
• Helmut H. Lukas · Carleton Place, CA
• Ursula Schick · Schriesheim, DE

Key dates

• Filing date: Dec 1, 1995
• Grant date: May 23, 2000
• Expiry date: Dec 1, 2015

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S977/915
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A medicament for immediately treating painful, inflammatory and/or febrile diseases contains as active substance ibuprofen as a racemate, as a racemic mixture with its enantiomers, as a pseudoracemate (mixtures of equal parts of S- and R-ibuprofen) or as a mixture of different parts of S- and R-ibuprofen in a range between pure S- and pure R-ibuprofen in the form of a pharmaceutically applicable nanosol and satisfies all requirements of an immediate-effect pharmaceutic form. It can in addition be combined with a slow-release medicament that contains as active substance ibuprofen as a racemic compound, as a pseudoracemate (mixtures of equal parts of S- and R-ibuprofen) or as a mixture of different parts of S- and R-ibuprofen in a range between pure S- and pure R-ibuprofen, in the form of a pharmaceutically applicable, gelatine-based nanosol.